BCL3 and ovarian cancer: These findings highlighted overexpressed LINC00176 as a contributing factor to EMT in ovarian cancer while silencing BCL3 or CP can reverse such alternation, which indicated that LINC00176 regulated EMT in ovarian cancer mediated by regulation of the BCL3 and CP protein.